3) The frequency and amplitude of the neural activity recorded from the SLGP, LSG and RSN were markedly increased by 1 hour intermittent hypoxia. (4) EMF reversed all these changes induced by 1 hour intermittent hypoxia.
METHODS Primary atrial myocytes were isolated and cultured from neonatal Sprague-Dawley rats (born 1-2 days). A single-pipette wholecell patch-clamp was used to investigate the acute effect of acehytisine on sodium channels, and RT-PCR and western blot were used to quantify a and b-subunits mRNA and protein expression implied chronic effect on sodium channels.
RESULTS Atrial myocytes were cultured and plated into coverlips at 1Â10 4 /cm 2 . 48h later, single cell was ruptured and I Na was recorded in absence and presence of acehytisine. It inhibited I Na in a positive ratedependent and concentration-dependent manner, with IC 50 value of 31.67AE5.47mmol/L. 50mmol/L acehytisine significantly shifted inactivation curves toward left and shifted activation curves to right, but did not modify the recovery kinetics from inactivation of sodium channels. In addition, incubation with 100mmol/L acehytisine for 3-24h caused significant decreases of a and b-subunits mRNA in timedependent manner (SCN5A decreased by 72.24AE18.21%, SCN1B decreased by 52.81AE19.77%, SCN3B decreased by 83.42AE35.16% at 24h, p <0.01 vs. untreated cells). Meanwhile, the quanification of protein levels was consistent with alteration of mRNA expression.
CONCLUSIONS These findings indicate that acehytisine inhibits sodium channels by two modes, 1) inhibiting I Na by binding to sodium channels and 2) downregulating a and b-subunits at mRNA and protein levels, which provides experimental evidence for anti-arrhythmia by acehytisine.
GW26-e2401
Enhanced levels of miR-122-5p and let-7b-3p in aortas of spontaneously hypertensive rats associated with downregulated levels of Apelin, miR-1-3p, miR-376b-3p and miR-298-5p OBJECTIVES The deregulation of microRNAs (miRNAs), a class of short and small non-coding RNAs, has been shown to be involved in a wide range of cellular processes and cardiovascular pathologies. The Apelin/APJ system has been implicated in the pathophysiology effects in cardiovascular system, which is a necessary process in the initiation and development of various cardiovascular diseases inclusive of hypertension. We hypothesized that Apelin is a negative regulator of hypertension-mediated pathological effects in spontaneously hypertensive rats (SHR) model.
METHODS
The 3-month-old male SHR and Wistar-Kyoto (WKY) rats were obtained from Slac Laboratory Animal Co. Ltd. in China. Rats received daily administration of Apelin or saline for 4 weeks. Systolic blood pressure (SBP) of rat was measured by the tail-cuff method. Vascular morphological analysis was processed using the computer image analysis software for the quantification of the media thickness (MT), lumen diameter (LD), and the ratio of MT to LD, markers of vascular hypertrophy and remodeling.
RESULTS In the SHR model, the aortic expression of miR-122-5p and let-7b-3p were upregulated, while miR-1-3p, miR-376b-3p and miR-298-5p were downregulated and negative correlated with SBP levels. Compared with WKY rats, the MT and the MT/LD ratio of the thoracic aorta were significantly enhanced in SHR [MT: (127.2AE4.5 um) vs.(81.8AE3.9 um); MT/LD ratio:(7.3AE1.1) vs.(4.8AE1.0); P<0.01, respectively]. These changes were linked with the reduction of Apelin expression and increased levels of ANF, and phosphorylated ERK1/2 as well as severe ultrastructural damage of the thoracic aorta. These effects were significantly blunted by Apelin treatment, in association with a lowering of phosphorylated ERK1/2 levels and improvement of ultrastructural injury. However, there were no changes in aortic expression of APJ receptor among groups.
CONCLUSIONS There are abnormal levels of miRNAs and Apelin in hypertensive status. In addition, Apelin is an important negative regulator of the hypertension-induced pathological hypertrophy and aortic remodeling and attenuates aortic ultrastructural injury in hypertensive rats. These observations indicate that various miRNAs and Apelin signaling in vasculature may be linked with hypertension and provide novel pharmacologic implications for the prevention and treatment of hypertension. 
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The Expression of Ubc9 and the Intensity of SERCA2a-SUMOylation Were Reduced in Diet-induced Obese Rats and Partially Restored by Trimetazidine Jing Yao, 1 Tian-Chang Li, 1 Xing-Hui Shao, 2 Zheng-Ming Xu, 1 Meng-Yue Yu, 2 Si-Yong Teng, 2 Yong-Jian Wu 2 1 Navy General Hospital, People's Liberation Army; 2 Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College OBJECTIVES Reduced expression of Sarcoplasmic reticulum calciumtransporting ATPase isoform 2a (SERCA2a) has been shown to play a significant role in the cardiac dysfunction of obese animal models. It was reported recently that SUMOylation enhances the stability and activity of SERCA2a. We hypothesized that SERCA2a-SUMOylation might be involved in obesity-mediated reduction of SERCA2a.
METHODS Trimetazidine (TMZ), the drug that inhibits fatty acid oxidation, was used in diet-induced obesity (DIO) rats and palmitic acid (PA)-treated cardiomyocytes. The intensity of SERCA2a-SUMOylation and proteins involved in SERCA2a-SUMOylation were investigated in vivo and in vitro.
RESULTS DIO rats presented cardiac dysfunction, which was alleviated by TMZ treatment. Reductions of SERCA2a protein and the intensity of SERCA2a-SUMOylation were observed in DIO rats and PA-treated cardiomyocytes. These reductions were partially restored by TMZ. However, TMZ itself did not alter the intensity of SERCA2a-SUMOylation in control cardiomyocytes. The variations of protein and mRNA levels of Ubc9 are in accordance with the intensity of SERCA2a-SUMOylation. Whereas the other proteins involved in SERCA2a-SUMOylation were not changed by DIO and PA.
CONCLUSIONS TMZ alleviates the DIO-induced and PA-induced reductions of SERCA2a-SUMOylation. Ubc9 is involved in the reductions.
GW26-e4628
Assessment of osteopontin, osteoprotegerin and activated monocytes/ macrophages on hypertensive patients with vascular calcification OBJECTIVES Multiple unbiased genome-wide wide association studies have identified a strong link between 9p21.3 locus and atherosclerotic disease risk. However, the direct mechanism accounting for the 9p21.3 CAD (Coronary Artery Disease) risk still remains poorly understood and controversial. Previous work including ours demonstrated that altered expression INK4/ ARF locus by non-coding RNA ANRIL might contribute to the 9p21.3 genetic atherosclerosis susceptibility. Studies from other groups also suggested possible physical interaction among 9p21.3, INK4/ARF locus and type I IFN gene cluster. However, recent study has showed that 9p21 locus does not affect risk of coronary artery disease through direct induction of type I IFNs.
METHODS To investigate whether type I IFN is co-regulated with INK4/ARF and contributes to clinical onset of CAD in Han Chinese, we first examined the relationship of IFN subtypes with 9p21.3 variants in 170 healthy individuals in US, followed by plasma IFNa21 measurement in 300 Han Chinese with CAD of different severity.
RESULTS
We found that mRNA expression of IFNa21 correlated with the expression of ARF and cANRIL, as well as rs10757278 CAD risk allele. The expression of IFNa21 did not correlate with CAD severity quantified by coronary angiography but was associated with the age of CAD onset in Han Chinese.
CONCLUSIONS These data suggest that type I IFNs does not contribute to CAD severity but may play a role in the age of onset of CAD, possibly through an ANRIL-mediated co-regulatory mechanism with INK4/ARF locus.
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Genetic diagnosis of familial hypercholesterolemia by targeted exome sequencing OBJECTIVES The aim of this study was to combine clinical criteria and next-generation sequencing (pyrosequencing) to establish a diagnosis of familial hypercholesterolemia (FH).
METHODS A total of 39 subjects with a Dutch Lipid Clinic Network score of !8 (definite FH clinical diagnosis) were recruited from the Lipid Clinic at Anzhen Hospital, Beijing, China. Next-generation sequencing was performed in all subjects using a GenCap Custom Enrichment Kit (MyGenostics, Beijing, China), a kit that detects in 167 disease genes, relevant with blood lipids and cholic acid metabolism, including low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), proprotein convertase subtilisin/kexin type 9 (PCSK9) 3 known FH-causing genes.
RESULTS A total of 24 mutations were detected in 39 subjects. Amongst these, 19 mutations were in the LDLR gene, three in the APOB gene and two in the PCSK9 gene. We also found 151 SNPs and 69 genes relevant with blood lipids. Of these, 40 high frequency SNPs and top 10 genes were summarized. The fourth, a mutation in LDLR has not previously been reported; it was found to segregate with high cholesterol levels in the family of the proband.
CONCLUSIONS Using a combination of clinical criteria and targeted exome sequencing, we have achieved FH diagnosis with a high success rate. Furthermore, we identified a new mutation in the LDLR gene.
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GPx-1P198L Over Expression Showed No protection Effect on Selenium Deficiency induced Cardiac Injury in Transgenic Mice
Suqin Wang, Guang Yang, Zhongwei Liu, Yanhe Zhu, Xiaolin Niu, Dengfeng Gao Second affiliated hospital of Xi'an Jiaotong University OBJECTIVES Our previous study showed that decreased GPx-1 activity in KD patients was associated with the GPx-1 Pro198Leu polymorphism and Se deficiency. The purpose of this study is to further elucidate the association between different Se levels and the GPx-1 P198L .
METHODS GPx-1 P198L transgenic mice (Tg) were generated and fed by control diet (CON, 0.1-0.2mg Se/kg) or Se-deficient diet (SD, <0.02 mg Se/kg) for 12 weeks. Heart GPX-1 expression was detected by realtime RT-PCR and western blot. Echocardiographic measurements were performed to measure the cardiac function. Serum Se was analyzed by a flameless atomic absorption spectrophotometry method. Myocardial GPx activity was spectrophotometrically measured using a cellular glutathione peroxidase activity assay kit. Caspase-9 and 3 levels were detected by western blot.
RESULTS
In GPx-1 P198L transgenic mice, heart GPx-1 expression was remarkable upregulated when compared with wide type (WT) control (P<0.05), whereas, GPx-1 activity showed no difference (P>0.05). Se deficiency resulted in cardiac systolic dysfunction both in WT and Tg mice and showed no difference (P>0.05). Se deficiency led to myocardial fibrosis accompanied by increased expression of caspase-9 and -3 In WT mice. But in Tg mice, expression levels of caspase-9 and -3 were attenuated, whereas, myocardial fibrosis was not significantly decreased.
CONCLUSIONS Overexpression of GPx-1 P198L did not show evident protection against cardiac remodeling and failure. These results further documented that GPx-1 P198L might be a functional polymorphism which may cause functional deficiency of GPx-1.
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Hypercholesterolemia abrogates the protective effect of ischemic postconditioning by induction of apoptosis and impairment of activation of reperfusion injury salvage kinase pathway Nan Wu, Dalin Jia Department of Cardiology, The First Affiliated Hospital of China Medical University OBJECTIVES Ischemic postcontioning (IPoC) is an effective method to prevent myocardial ischemia reperfusion injury (MIRI), but its cardioprotection is usually blocked in the presence of hypercholesterolemia (HC) and the potential mechanism is still unknown.
METHODS In this study, we investigated the roles of reperfusion injury salvage kinase (RISK) and apoptosis-related pathways in the attenuation of cardioprotection of IPoC in the presence of HC.
RESULTS
The results showed that IPoC significantly decreased the infarct size and apoptosis, improved the recovery of ischemic myocardium, but these beneficial effects were reversed by high cholesterol diet-induced HC. Moreover, we also found that HC inhibited the phosphorylation of Akt and ERK1/2 which usually activated by IPoC in normal heart, induced excessive apoptosis by downregulating Bcl-2 and up-regulating Bax, cytochrome c, caspase 9 and caspase 3 when compared with that in normal heart.
CONCLUSIONS Taken together, our results demonstrated that the cardioprotection of IPoC was abolished by HC, which was associated with inactivation of RISK signal pathway and dysregulation of downstream apoptosis-related pathway.
